Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome
NCT00345852 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2007-06-29
Summary
This is a study to compare two treatments (amnioreduction vs. selective fetoscopic laser photocoagulation \[SFLP\]) in patients with severe twin to twin transfusion syndrome.
Conditions
- Twin to Twin Transfusion Syndrome
Interventions
- PROCEDURE
-
Fetoscopic Selective Laser Photocoagulation
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
collaborator OTHER -
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
Timothy M Crombleholme, MD · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-03-31
- Completion
- 2007-05-31
Countries
- United States
Study Locations
More Related Trials
-
Premature Infants in Need of Transfusion (PINT)
NCT00182390 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
NCT01203514 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
NCT02564796 ·Status: TERMINATED ·Phase: PHASE2
-
RBC Irradiation, Anemia and Gut Injury
NCT02741648 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy
NCT01550627 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
NCT04584983 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Correlation Between Red Cell Transfusion and Complications of Prematurity
NCT07123948 ·Status: NOT_YET_RECRUITING
-
Red Blood Cell (RBC) Survival Following Transfusion in Infants
NCT00731588 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid
NCT01094977 ·Status: SUSPENDED ·Phase: PHASE3
-
Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage
NCT03390530 ·Status: WITHDRAWN ·Phase: PHASE3
-
Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates
NCT02612727 ·Status: COMPLETED ·Phase: NA
-
umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)
NCT05100212 ·Status: COMPLETED ·Phase: PHASE2
-
Neonatal Erythropoietin in Asphyxiated Term Newborns
NCT00719407 ·Status: COMPLETED ·Phase: PHASE1
-
Withholding Feeds During Red Blood Cell Transfusion and TRAGI
NCT02132819 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia
NCT02965638 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Amnioinfusion for Intrauterine Neuroprotection
NCT05513690 ·Status: UNKNOWN ·Phase: NA
-
Complications of Exchange Transfusion in Neonates
NCT03195049 ·Status: UNKNOWN ·Phase: NA
-
Blood Transfusions in Preterm Infants
NCT05331235 ·Status: UNKNOWN
-
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
NCT06984445 ·Status: RECRUITING
-
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
NCT04598750 ·Status: RECRUITING
-
Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants
NCT01340339 ·Status: UNKNOWN ·Phase: PHASE4
-
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
NCT00589953 ·Status: TERMINATED ·Phase: PHASE2
-
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Stannsoporfin in Neonates
NCT02685137 ·Status: COMPLETED ·Phase: PHASE3
-
New Phototherapy Device to Treat Patients With Crigler-Najjar Disease
NCT02356978 ·Status: UNKNOWN ·Phase: NA